From Ozempic to Oral Pills: The New Breakthrough in Weight Loss Medicine
GLP-1 drugs have changed the conversation around weight loss and blood sugar control in the US, but most of…
GLP-1 drugs have changed the conversation around weight loss and blood sugar control in the US, but most of…
Starting a treatment journey with GLP-1 pills marks a major milestone in managing metabolic health. These medications originally required…
Eli Lilly recently shared excellent news about a novel medication. The company tested the investigational drug orforglipron in extensive…
Eli Lilly has unveiled striking results from a head-to-head clinical trial showing its experimental oral GLP-1 pill, Orforglipron, outperformed…
A new economic analysis finds that oral semaglutide may save money and improve outcomes for patients with type 2…
Eli Lilly and Company is accelerating its push into the fast-growing obesity drug market. However, its renewed focus on…
A new study has placed salcaprozate sodium, known as SNAC, under scientific scrutiny. Researchers warn that this widely used…
Shares of Eli Lilly and Company moved higher this week after the drugmaker signaled strong confidence in its upcoming…
More than a third of patients who started taking Novo Nordisk’s Wegovy pill had never used a GLP-1 drug…
Pharmaceutical companies are racing to transform weight‑loss treatment. They are shifting from weekly injections to daily pills, opening easier…